The project began with an investigation of Gipie (CCDC88B) expression; mass spectrometry‐based proteomics (SWATH LC MS/MS) and western blots were used to determine the silencing of Gipie in immune cells and cancer cells (Figure S1). Here, CCDC88B is linked to cancer.